SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-006295
Filing Date
2022-08-19
Accepted
2022-08-19 13:20:51
Documents
15
Period of Report
2022-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm   iXBRL 8-K 26949
2 PRESS RELEASE curr_ex991.htm EX-99.1 15402
  Complete submission text file 0001477932-22-006295.txt   159602

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA curr-20220816.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20220816_lab.xml EX-101.LAB 12618
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20220816_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20220816_pre.xml EX-101.PRE 7881
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20220816_def.xml EX-101.DEF 2099
9 EXTRACTED XBRL INSTANCE DOCUMENT curr_8k_htm.xml XML 3171
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 221179952
SIC: 2834 Pharmaceutical Preparations